APPENDIX A - ACS Symposium Series (ACS Publications)

APPENDIX A Assessment of the Aquatic Release and Relevance of Selected Endogenous Chemicals: Androgens, Thyroids, and Their in Vivo Metabolites

Downloaded by PENNSYLVANIA STATE UNIV on June 24, 2012 | http://pubs.acs.org Publication Date (Web): November 2, 2010 | doi: 10.1021/bk-2010-1048.ot001

Usman Khan and Jim Nicell* Department of Civil Engineering and Applied Mechanics, McGill University, 817 Sherbrooke Street West, Montreal, Quebec H3A 2K6 *E-mail: [email protected]

© 2010 American Chemical Society In Contaminants of Emerging Concern in the Environment: Ecological and Human Health Considerations; Halden, R.; ACS Symposium Series; American Chemical Society: Washington, DC, 2010.

562


Table A.I. Total per capita daily urinary (Ut) excretion of 5α-androstane-3α17βdiol and its conjugated and unconjugated fractions (Fu•Ut, Gu•Ut, Su•Ut)

In Contaminants of Emerging Concern in the Environment: Ecological and Human Health Considerations; Halden, R.; ACS Symposium Series; American Chemical Society: Washington, DC, 2010.

563


Table A.II. Total per capita daily urinary excretion (Ut) of etiocholanolone and its conjugated and unconjugated fractions (Fu•Ut, Gu•Ut, Su•Ut)


564


Table A.III. Total per capita daily urinary excretion (Ut) of epitestosterone and its conjugated and unconjugated fractions (Fu•Ut, Gu•Ut, Su•Ut)


565


Table A.IV. Total per capita daily urinary excretion (Ut) of dehydroepiandrosterone and its conjugated and unconjugated fractions (Fu•Ut, Gu•Ut, Su•Ut)


566


Table A.V. Total per capita daily urinary excretion (Ut) of androstane-3,11,17-trione, (5.α) and its conjugated and unconjugated fractions (Fu•Ut, Gu•Ut, Su•Ut)


567


Table A.VI. Total per capita daily urinary excretion (Ut) of androstenetriol and its conjugated and unconjugated fractions (Fu•Ut, Gu•Ut, Su•Ut)


568


Table A.VII. Total per capita daily urinary excretion (Ut) of androstane-3,17-dione, (5β) and its conjugated and unconjugated fractions (Fu•Ut, Gu•Ut, Su•Ut)


569


Table A.VIII. Total per capita daily urinary excretion (Ut) of 11β-hydroxyandrosterone and its conjugated and unconjugated fractions (Fu•Ut, Gu•Ut, Su•Ut)


570


Table A.IX. Total per capita daily urinary excretion (Ut) of 11β-hydroxyetiocholanolone and its conjugated and unconjugated fractions (Fu•Ut, Gu•Ut, Su•Ut)


571


Table A.X. Total per capita daily urinary excretion (Ut) of androsterone and its conjugated and unconjugated fractions (Fu•Ut, Gu•Ut, Su•Ut)


572


Table A.XI. Total per capita daily urinary excretion (Ut) of 5α-androstanedione and its conjugated and unconjugated fractions (Fu•Ut, Gu•Ut, Su•Ut)


573


Table A.XII. Total per capita daily urinary excretion (Ut) of 11-ketoandrosterone and its conjugated and unconjugated fractions (Fu•Ut, Gu•Ut, Su•Ut)


574


Table A.XIII. Total per capita daily urinary excretion (Ut) of 11-ketoetiocholanolone and its conjugated and unconjugated fractions (Fu•Ut, Gu•Ut, Su•Ut)


575


Table A.XIV. Total per capita daily urinary excretion (Ut) of 5β-androstane-3-11-17-trione and its conjugated and unconjugated fractions (Fu•Ut, Gu•Ut, Su•Ut)


576


Table A.XV. Total per capita daily urinary excretion (Ut) of androst-4-ene-3,6,17-trione and its conjugated and unconjugated fractions (Fu•Ut, Gu•Ut, Su•Ut)


577


Table A.XVI. Total per capita daily urinary excretion (Ut) of 5β-androstane-3α17βdiol and its conjugated and unconjugated fractions (Fu•Ut, Gu•Ut, Su•Ut)


578


Table A.XVII. Total per capita daily urinary excretion (Ut) of reverse triiodothyronine (rT3), 3’,5’-diiodo-L-thyronine (3’,5’T2), 3,3’-diiodothyronine (3’,3’T2) and thyronine (To) and its conjugated and unconjugated fractions (Fu•Ut, Gu•Ut, Su•Ut)



579 Figure A.1. Percent reduction in effluent loads if sulphate conjugates are made available for treatment.


References 1.

2.


3.

4.

5.

6. 7. 8.

9.

10.

11.

12.

13.

14.

Southan, G. J.; Brooks, R. V.; Cowan, D. A.; Kicman, A. T.; Unnadkat, N.; Walker, C. J. Possible indices for the detection of the administration of dihydrotestosterone to athletes. J. Steroid Biochem. Mol. Biol. 1992, 42 (1), 87–94. Berthou, F. L.; Bardou, L. G.; Floch, H. H. Measurement of 5.alpha.androstane-3.alpha., 17.beta.-diol and 5.beta.-androstane-3.alpha., 17.beta.-diol in the urine of healthy men and women. J. Steroid Biochem. 1971, 2 (2), 141–153. Muller, L.; Phillipou, G. Quantification of 5 alpha- and 5 betaandrostanediols in urine by gas chromatography-mass spectrometry. Clin. Chem. 1987, 33(2 Pt 1), 256−260. Mareck-Engelke, U.; Geyer, H.; Donike, M. Stability of Steroid Profiles (4): The Circadian Rhythm of Urinary Ratios and Excretion Rates of Endogenous Steroids in Female and Its Menstrual Dependency, Proceedings of the 12th Cologne Workshop on Dope Analysis, Cologne, Germany, April 1994. Bricout, V. A.; Wright, F.; Lagoguey, M. Urinary profile of androgen metabolites in a population of sportswomen during the menstrual cycle. Int. J. Sports Med. 2003, 24 (3), 197–202. Juricskay, S.; Telegdy, E. Urinary steroids in women with androgenic alopecia. Clin. Biochem. 2000, 33 (2), 97–101. U.S. Census Bureau. http://www.census.gov/ipc/www/idb/ informationGateway.php (accessed October 14, 2009). Dehennin, L.; Lafarge, P.; Dailly, P.; Bailloux, D.; Lafarge, J. P. Combined profile of androgen glucuro- and sulfoconjugates in post-competition urine of sportsmen: A simple screening procedure using gas chromatography-mass spectrometry. J. Chromatogr., B 1996, 687 (1), 85–89. Weykamp, C. W.; Penders, T. J.; Schmidt, N. A.; Borburgh, A. J.; Van de Calseyde, J. F.; Wolthers, B. J. Steroid profile for urine: Reference values.Clin. Chem. 1989, 35(12), 2281−2284. Slob, A.; Winkel, P. Normal values for the urinary excretion of some 17oxosteroids and pregnanediols in healthy male adolescents. Clin. Chim. Acta 1973, 44 (3), 307–318. Remer, T.; Boye, K. R.; Hartmann, M. F.; Wudy, S. A. Urinary markers of adrenarche: Reference values in healthy subjects, aged 3−18 years. J. Clin. Endocrinol. Metab. 2005, 90 (4), 2015–202. Shamim, W.; Yousufuddin, M.; Bakhai, A.; Coats, A. J. S.; Honour, J. W. Gender differences in the urinary excretion rates of cortisol and androgen metabolites. Ann. Clin. Biochem. 2000, 37 (6), 770–774. Rose, R. M.; Bourne, P. G.; Poe, R. O.; Mougey, E. H.; Collins, D. R.; Mason, J. W. Androgen responses to stress. II. Excretion of testosterone, epitestosterone, androsterone, and etiocholanolone during basic combat training and under threat of attack. Psychosom. Med. 1969, 31 (5), 418–436. Kirschner, M. A.; Lipsett, M. B. The analysis of urinary steroids using gas−liquid chromatography. Steroids 1964, 3 (3), 277–294. 580



15. Kirschner, M. A.; Lipsett, M. B. Gas−liquid chromatography in the quantitative analysis of urinary 11-deoxy-17-ketosteroids. The J. Clin. Endocrinol. Metab. 1963, 23, 255-260. 16. Shackleton, C. H. L. Profiling steroid hormones and urinary steroids. J. Chromatogr., B 1986, 379, 91–156. 17. Kreze, A.; Galvanek, M. The creatinine index of individual urinary 17-oxosteroids in normal subjects. J. Endocrinol. 1971, 49 (1), 175–176. 18. Wang, D. Y.; Bulbrook, R. D.; Hayward, J. L. Urinary and plasma androgens and their relation to familial risk of breast cancer. Eur. J. Cancer 1975, 11 (12), 873–877. 19. Skoldefors, H.; Carlstrom, K.; Furuhjelm, M. Influence of aging upon the urinary hormone excretion in the male. Acta Obstet. Gynecol. Scand. 1976, 55 (2), 119–123. 20. Deslypere, J. P.; Wiers, P. W.; Sayed, A.; Vermeulen, A. Urinary excretion of androgen metabolites, comparison with excretion of radioactive metabolites after injection of [4-14C]testosterone. Influence of age. Acta Endocrinol. 1981, 96 (2), 265–272. 21. Freeman, H.; Parsons, O. A.; Feffer, M. H.; Phillips, L.; Daneman, E. A.; Elmadjian, F.; Bloch, E.; Dorfman, R. I.; Pincus, G. Steroid replacement in aged men. J. Clin. Endocrinol. Metab. 1956, 16, 779–789. 22. Wang, C.; Catlin, D. H.; Starcevic, B.; Heber, D.; Ambler, C.; Berman, N.; Lucas, G.; Leung, A.; Schramm, K.; Lee, P. W. N.; Hull, L.; Swerdloff, R. S. Low-fat high-fiber diet decreased serum and urine androgens in men. J. Clin. Endocrinol. Metab. 2005, 90 (6), 3550–3559. 23. Lukaszewska, J. H.; Obuchowicz-Fidelus, B. Serum and urinary steroids in women athletes. J. Sports Med. Phys. Fitness 1985, 25 (4), 215–221. 24. Vandekerckhove, D.; Vanluchene, E.; Aerstens, W.; Van Maele, G.; De Boever, J. Neutral Urinary Steroids and Estrogen Receptors in Early Breast Cancer. Proceedings of the IX Meeting of the International Study Group for Steroid Hormones, Rome, December 5−7, 1979. 25. Hendrikx, A.; Heyns, W.; Steeno, O.; De Moor, P. Influence of body size, changes in body weight and/or food intake on urinary excretion of 11-desoxy- 17-ketosteroid. In Androgens in Normal and Pathological Conditions; Vermeulen, A., Ed.; Excerpta Medica Foundation: Amsterdam, 1963; 63−70. 26. Thomas, B. S.; Bulbrook, R. D.; Hayward, J. L.; Kumaoka, S.; Takatani, O.; Abe, O.; Utsunomiya, J. Urinary steroid profiles in normal women and in patients with breast cancer in Britain and Japan: Relation to thyroid function. Eur. J. Cancer 1977, 13 (11), 1287–1292. 27. Mareck-Engelke, U.; Geyer, H.; Donike, M. Stability of Steroid Profiles (3): Ratios and Excretion Rates of Endogenous Steroids in Male Urines Collected over 24 Hours, Proceedings of the 12th Cologne Workshop on Dope Analysis, Cologne, Germany, April 1994. 28. Paxton, J. W.; Moore, M. R.; Beattie, A. D.; Goldberg, A. Urinary excretion of 17-oxosteroids in hereditary coproporphyria. Clin. Sci. Mol. Med. 1975, 49 (5), 441–444. 581 In Contaminants of Emerging Concern in the Environment: Ecological and Human Health Considerations; Halden, R.; ACS Symposium Series; American Chemical Society: Washington, DC, 2010.


29. Gupta, D. Separation and estimation of testosterone and epitestosterone in the urine of pre-pubertal children. Steroids 1967, 10 (4), 457–471. 30. Dalzell, D. P.; el-Attar, T. M. Gas chromatographic determination of urinary excretion of testosterone, epitestosterone, and androstenedione in pre-adolescent and adolescent children. J. Clin. Endocrinol. Metab. 1973, 36 (6), 1237–1243. 31. McRoberts, J. W.; Olson, A. D.; Herrmann, W. L. Determination of urinary testosterone and epitestosterone in men, women, and children. Clin. Chem. 1968, 14(6), 565−582. 32. Brooks, R. V. A method for the simultaneous estimation of testosterone and epitestosterone in urine. Steroids 1964, 4 (1), 117–124. 33. Raynaud, E.; Audran, M.; Pages, J. C.; Fedou, C.; Brun, J. F.; Chanal, J. L.; Osetti, A. Determination of urinary testosterone and epitestosterone during pubertal development: A cross-sectional study in 141 normal male subjects. Clin. Endocrinol. 1993, 38(4), 353−359. 34. De Nicola, A. F.; Dorfman, R. I.; Forchielli, E. Urinary excretion of epitestosterone and testosterone in normal individuals and hirsute and virilized females. Steroids 1966, 7 (4), 351–366. 35. Pal, S. B. Urinary excretion of testosterone and epitestosterone in men, women and children, in health and disease. Clin. Chim. Acta 1971, 33 (1), 215–227. 36. Sparagana, M. Quantitative gas−chromatographic analysis of urinary testosterone and epitestosterane. Steroids 1965, 5 (6), 773–789. 37. Marenich, L. P. Testosterone, epitestosterone, androstenedione, and 7-ketodehydroepiandrostenedione excretion in healthy men of different ages. Probl. Endokrinol. 1979, 25 (4), 28–31. 38. Ingiulla, W.; Forleo, R.; Galli, A.; Severi, S. Clinical Evaluation of Urinary Testosterone and Epitestosterone in the Human. In Gas Chromatographic Determination of Hormonal Steroids; Polvani, F., Surace, M., Luisi, M., Eds.; Academic Press: New York, 1967; 183−197. 39. France, J. T.; Knox, B. S. Urinary excretion of testosterone and epitestosterone in hirsutism. Acta Endocrinol. 1967, 56 (2), 177–187. 40. Tajic, M.; Kovacic, E. Free, glucuronide, and sulfate testosterone, epitestosterone, and androstenedione in the urine. Naturwissenschaften 1968, 55 (8), 394. 41. Mareck-Engelke, U.; Flenker, U.; Donike, M. Stability of Steroid Profiles (5): The Annual Rhythm of Urinary Ratios and Excretion Rates of Endogenous Steroids in Female and Its Menstrual Dependency, Proceedings of the 13th Cologne Workshop on Dope Analysis, Cologne, Germany, March 1995. 42. Longhino, N.; Tajic, M.; Vedris, M.; Jankovic, D.; Drobnjak, P. Urinary excretion of androstenedione, testosterone, epitestosterone, and dehydroepiandrosterone during the normal menstrual cycle. Acta Endocrinol. 1968, 59 (4), 644–651. 43. Arguelles, A. E.; Poggi, U. L.; Saborida, C.; Hoffman, C.; Chekherdemian, M.; Blanchard, O. Endocrine profiles and breast cancer. Lancet 1973, 1 (7796), 165–168. 582 In Contaminants of Emerging Concern in the Environment: Ecological and Human Health Considerations; Halden, R.; ACS Symposium Series; American Chemical Society: Washington, DC, 2010.


44. Menini, E. The indirect analysis of 17-oxosteroid glucosiduronates and sulfates in human urine. Biochem. J. 1966, 99, 747–759. 45. Chemama, R.; Baulieu, E. E.; Crepey, O.; Jayle, M. F. Conjugation of 11hydroxy-17-ketosteroids with glycuronides and sulfates in urine in man. C. R. Seances Soc. Biol. Ses Fil. 1957, 151 (3), 452–454, abstract only. 46. Faber, J.; Busch-Sorensen, M.; Rogowski, P.; Kirkegaard, C.; SiersbaekNielsen, K.; Friis, T. Urinary excretion of free and conjugated 3′,5′diiodothyronine and 3,3′-diiodothyronine. J. Clin. Endocrinol. Metab. 1981, 53 (3), 587–593. 47. Willetts, P.; Ramsden, D. B.; Crossley, D. N.; Hoffenberg, R. Measurement of Thyronine (T0) in Urine Using Gas Chromatography Mass Fragmentography. In 8th International Thyroid Congress, Sydney, Australia, 1980.

583 In Contaminants of Emerging Concern in the Environment: Ecological and Human Health Considerations; Halden, R.; ACS Symposium Series; American Chemical Society: Washington, DC, 2010.

APPENDIX A - ACS Symposium Series (ACS Publications)

Recommend Documents